Our Team

Our team includes pioneers in genome editing and leaders in cell and gene therapy who are committed to solving significant medical problems.

Michael Amoroso

President, Chief Executive Officer

Jeff Smith, Ph.D.

Chief Research Officer

Cindy Atwell

Chief Development and Business Officer

Alex Kelly

Chief Financial Officer

Dario Scimeca

General Counsel

Cassie Gorsuch, Ph.D

Chief Scientific Officer

Neil Leatherbury

Senior Vice President of Chemistry, Manufacturing, and Controls (CMC)

Juli Blanche

Chief People Officer

Naresh Tanna

Chief of Staff to CEO and Head of Investor Relations

Kevin Buehler

Michael Amoroso

President, Chief Executive Officer

Melinda Brown

Stanley Frankel, M.D.

Geno Germano

Shari Lisa Piré, J.D.

Raymond Schinazi, Ph.D., DSc

Hepatitis B Advisor

Professor Mark Sulkowski, M.D.

Hepatitis B Advisor

Jordan Feld M.D., MPH, FAASLD

Hepatitis B Advisor

Alan List, M.D.

Scientific Advisor

Our team includes pioneers in genome editing and leaders in cell and gene therapy who are committed to solving significant medical problems.

Michael Amoroso

Jeff Smith, Ph.D.

Cindy Atwell

Alex Kelly

Dario Scimeca

Cassie Gorsuch, Ph.D

Neil Leatherbury

Juli Blanche

Naresh Tanna

Kevin Buehler

Michael Amoroso

Melinda Brown

Stanley Frankel, M.D.

Geno Germano

Shari Lisa Piré, J.D.

Raymond Schinazi, Ph.D., DSc

Professor Mark Sulkowski, M.D.

Jordan Feld M.D., MPH, FAASLD

Alan List, M.D.

Contact Info

Learn More

heading

Policies